{"doi":"10.1016/s0093-7754(03)00251-3","title":"Antibodies for the treatment of diffuse large cell lymphoma","abstract":null,"journal":"Seminars in Oncology","year":2003,"id":17456,"datarank":1.6829280104752424,"base_score":2.9444389791664403,"endowment":2.9444389791664403,"self_citation_contribution":0.44166584687496613,"citation_network_contribution":1.2412621636002763,"self_endowment_contribution":0.44166584687496613,"citer_contribution":1.2412621636002763,"corpus_percentile":null,"corpus_rank":null,"citation_count":18,"citer_count":18,"citers_with_citation_signal":14,"citers_with_endowment":14,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":11098,"name":"Nancy L. Bartlett","orcid":"0000-0001-8470-394X","position":1,"is_corresponding":false},{"id":124824,"name":"Kristie A. Blum","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":2.9444389791664403,"endowment":2.9444389791664403,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"12939713","pmcid":null,"openalex_id":"https://openalex.org/W2069548725","authors":[],"funders":[],"total_grants":0,"fwci":2.2114,"citation_percentile":0.86902617,"influential_citations":0,"citation_trend":[{"year":2015,"count":2}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0093775403002513?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0093775403002513?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/s0093-7754(03)00251-3","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/12939713","host_type":"repository"}],"fields_of_study":["Lymphoma Diagnosis and Treatment","CAR-T cell therapy research","Monoclonal and Polyclonal Antibodies Research","Medicine","Antibodies, Monoclonal","Antibodies, Monoclonal, Murine-Derived","Antigens, CD20","Antineoplastic Agents","Combined Modality Therapy","Disease-Free Survival","Humans","Lymphoma, Large B-Cell, Diffuse","Neoplasm Recurrence, Local","Rituximab"],"mesh_terms":["Rituximab","Antibodies, Monoclonal","Antineoplastic Agents","Combined Modality Therapy","Humans","Neoplasm Recurrence, Local","Lymphoma, Large B-Cell, Diffuse","Disease-Free Survival","Antigens, CD20","Antibodies, Monoclonal, Murine-Derived"],"keywords":["Rituximab","Medicine","Lymphoma","Monoclonal antibody","CD20","Chemotherapy","Monoclonal antibody therapy","Oncology","Antibody","Monoclonal","Immunology","Aggressive lymphoma","Chemotherapy regimen","Internal medicine","Cancer research"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-02T19:00:24.938382Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}